Summary

The global patient handling equipment market is projected to reach USD 17.29 billion by 2031 from USD 13.04 billion in 2026, at a CAGR of 5.77% during the forecast period. The patient handling equipment market is driven by an aging population, rising mobility limitations, increasing caregiver injuries, and a growing emphasis on safe patient handling. Expansion of home healthcare, rehabilitation, and long-term care further supports equipment adoption. Opportunities arise from AI-enabled monitoring, connected devices, robotics, and smart mobility equipment. However, high equipment costs, limited reimbursement in some markets, and budget constraints can restrict adoption. Key challenges include inadequate caregiver training, maintenance requirements, interoperability issues, cybersecurity risks for connected devices, and limited access to assistive technologies in developing regions. WHO estimates that more than 2.5 billion people need assistive products globally. By type, the medical beds segment held the second-largest share in the patient handling equipment market in 2025. By type, the patient handling equipment market is segmented into patient transfer devices, medical beds, mobility equipment, bathroom & toilet assist equipment, and stretchers & transport chairs. In 2025, the medical beds segment held the second-largest market share. The medical beds segment is further categorized into Electric Beds, Manual Beds, Semi-electric Beds, and Smart Beds. The medical beds segment holds a major share because these beds are essential across hospitals, rehabilitation facilities, long-term care centers, and home healthcare settings. These beds support patient positioning, mobility, comfort, pressure management, and safe caregiving, making them fundamental to patient handling workflows. Demand is further supported by the aging population and increasing prevalence of chronic conditions requiring prolonged care. By end user, the rehabilitation facilities segment is expected to grow at the highest CAGR during the forecast period. The market is segmented by application into hospitals, home healthcare, elder care facilities, rehabilitation facilities, and others. The rehabilitation facilities segment is expected to grow at the highest CAGR as demand for rehabilitation increases among patients affected by aging, injuries, neurological conditions, musculoskeletal disorders, and chronic diseases. WHO estimates that 2.4 billion people globally live with conditions that could benefit from rehabilitation. Rehabilitation facilities require patient lifts, transfer equipment, medical beds, wheelchairs, and mobility aids to support safe transfers, therapy, positioning, and functional recovery. A growing emphasis on restoring independence and strengthening rehabilitation services is expected to increase adoption of patient handling equipment in these facilities during the forecast period. US to grow at the highest CAGR for North America patient handling equipment market. The patient handling equipment market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held the second largest share in the patient handling equipment market in 2025. The North American patient handling equipment market is divided into the US and Canada. In 2025, the US held the major share in the North America patient handling equipment market. This is due to its large healthcare system, substantial healthcare expenditure, aging population, and established reimbursement infrastructure. The US population aged 65 and older reached 61.2 million in 2024, representing 18.0% of the population and creating significant demand for mobility and patient-care equipment. US healthcare spending reached USD 5.3 trillion in 2024, or 18.0% of GDP, underscoring the scale of healthcare investment. Medicare also covers several relevant durable medical equipment categories, including patient lifts, hospital beds, wheelchairs, walkers, and commode chairs, supporting access for eligible beneficiaries. Additionally, FDA guidance and safe-patient-handling initiatives support adoption of appropriate lifting technologies to reduce patient and caregiver injury risks. MARKET BREAKDOWN: A breakdown of the primary participants referred to for this report is provided below: ・By Company Type: Tier 1 - 28%, Tier 2 - 34%, and Tier 3 - 38% ・By Designation: C-level - 40%, Director level - 26%, and Others - 34% ・By Region: North America - 25%, Europe - 41%, the Asia Pacific - 30%, Latin America - 3%, and the Middle East & Africa - 1%. Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.0 billion, Tier 2 = USD 1.0 billion to USD 10.0 billion, and Tier 3 =

ページTOPに戻る

Table of Contents

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 STUDY SCOPE 36
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 36
1.3.2 INCLUSIONS & EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 38
1.3.4 CURRENCY CONSIDERED 38
1.4 STAKEHOLDERS 39
1.5 SUMMARY OF CHANGES 39
2 EXECUTIVE SUMMARY 40
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 40
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 41
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 42
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 43
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 44
3 PREMIUM INSIGHTS 45
3.1 PATIENT HANDLING EQUIPMENT MARKET OVERVIEW 45
3.2 EUROPE: PATIENT HANDLING EQUIPMENT MARKET, BY END USER 46
3.3 PATIENT HANDLING EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47
3.4 PATIENT HANDLING EQUIPMENT MARKET: REGIONAL MIX 47
3.5 PATIENT HANDLING EQUIPMENT MARKET: DEVELOPED COUNTRIES VS. EMERGING ECONOMIES 48
4 MARKET OVERVIEW 49
4.1 INTRODUCTION 49
4.2 MARKET DYNAMICS 49
4.2.1 DRIVERS 50
4.2.1.1 Expanding geriatric population and increasing cases of obesity 50
4.2.1.2 High risk of caregiver injuries during manual patient handling 50
4.2.1.3 Rising number of hospital admissions 50
4.2.2 RESTRAINTS 51
4.2.2.1 Shortage of trained personnel in emerging economies 51
4.2.3 OPPORTUNITIES 51
4.2.3.1 Rising demand for home healthcare services 51
4.2.4 CHALLENGES 51
4.2.4.1 Challenges associated with bariatric patient handling 51
4.2.4.2 Improper architectural designs in healthcare facilities 52
4.3 UNMET NEEDS & WHITE SPACES 52
4.3.1 UNMET NEEDS 53
4.3.2 WHITE SPACE OPPORTUNITIES 53
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 54
4.4.1 INTERCONNECTED MARKETS 54
4.4.2 CROSS-SECTOR OPPORTUNITIES 54
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 55
5 INDUSTRY TRENDS 56
5.1 PORTER’S FIVE FORCES ANALYSIS 56
5.1.1 THREAT OF NEW ENTRANTS 57
5.1.2 BARGAINING POWER OF SUPPLIERS 58
5.1.3 BARGAINING POWER OF BUYERS 58
5.1.4 THREAT OF SUBSTITUTES 58
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 58
5.2 MACROECONOMIC OUTLOOK 59
5.2.1 INTRODUCTION 59
5.2.2 GDP TRENDS & FORECAST 59
5.2.3 TRENDS IN REHABILITATION EQUIPMENT INDUSTRY 61
5.3 SUPPLY CHAIN ANALYSIS 61
5.4 VALUE CHAIN ANALYSIS 62
5.5 ECOSYSTEM ANALYSIS 64
5.6 PRICING ANALYSIS 65
5.6.1 AVERAGE SELLING PRICE TREND OF KEY PATIENT HANDLING PRODUCTS, BY KEY PLAYER (2023–2025) 65
5.6.2 AVERAGE SELLING PRICE TREND OF KEY PATIENT HANDLING PRODUCTS, BY REGION (2023–2025) 66
5.7 TRADE ANALYSIS 67
5.7.1 IMPORT SCENARIO FOR HS CODE 9402 67
5.7.2 EXPORT SCENARIO FOR HS CODE 9402 67
5.8 KEY CONFERENCES AND EVENTS, 2026–2027 68
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 69
5.10 INVESTMENT & FUNDING SCENARIO 69
5.11 IMPACT OF 2025 US TARIFFS ON PATIENT HANDLING EQUIPMENT MARKET 70
5.11.1 INTRODUCTION 70
5.11.2 KEY TARIFF RATES 71
5.11.3 PRICE IMPACT ANALYSIS 72
5.11.4 IMPACT ON COUNTRIES/REGIONS 72
5.11.4.1 North America 72
5.11.4.2 Europe 72
5.11.4.3 Asia Pacific 72
5.11.5 END-USE INDUSTRY IMPACT 73
6 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 74
6.1 DECISION-MAKING PROCESS 74
6.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 74
6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 74
6.2.2 KEY BUYING CRITERIA 75
6.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 76
6.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 76
6.5 MARKET PROFITABILITY 77
6.5.1 REVENUE POTENTIAL 77
6.5.2 COST DYNAMICS 77
6.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 77
7 SUSTAINABILITY & REGULATORY LANDSCAPE 79
7.1 REGIONAL REGULATIONS AND COMPLIANCE 79
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
7.1.2 INDUSTRY STANDARDS 81
7.2 SUSTAINABILITY INITIATIVES 82
7.2.1 CARBON IMPACT & ECO-APPLICATIONS 82
7.2.1.1 Carbon impact reduction 83
7.2.1.2 Eco-applications 83
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 83
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 84
7.5 REIMBURSEMENT ANALYSIS 85
8 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 86
8.1 KEY EMERGING TECHNOLOGIES 86
8.1.1 IOT-ENABLED & CONNECTED PATIENT HANDLING EQUIPMENT 86
8.1.2 SMART SENSORS & LOAD-MONITORING SYSTEMS 86
8.2 COMPLEMENTARY TECHNOLOGIES 86
8.2.1 HEALTH INFORMATION EXCHANGE 86
8.2.2 ELECTRONIC HEALTH RECORDS (EHR) INTEGRATION 87
8.3 TECHNOLOGY/PRODUCT ROADMAP 87
8.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 87
8.3.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 88
8.3.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 88
8.4 PATENT ANALYSIS 89
8.4.1 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 90
8.5 FUTURE APPLICATIONS 90
8.5.1 AI-ENABLED PATIENT HANDLING, FALL PREVENTION, AND INTELLIGENT MOBILITY 91
8.5.2 CONNECTED PATIENT HANDLING, REMOTE MONITORING, AND SMART CARE ECOSYSTEMS 91
8.6 IMPACT OF AI/GEN AI ON PATIENT HANDLING EQUIPMENT MARKET 92
8.6.1 TOP USE CASES & MARKET POTENTIAL 92
8.6.2 CASE STUDIES OF AI IMPLEMENTATION IN PATIENT HANDLING EQUIPMENT MARKET 93
8.6.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 93
8.6.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PATIENT HANDLING EQUIPMENT MARKET 94
9 PATIENT HANDLING EQUIPMENT MARKET, BY TYPE 95
9.1 INTRODUCTION 96
9.2 PATIENT TRANSFER DEVICES 96
9.2.1 PATIENT LIFTS 97
9.2.1.1 Ceiling lifts 98
9.2.1.1.1 Ceiling lifts accounted for largest market share in 2025 98
9.2.1.2 Stair & wheelchair lifts 99
9.2.1.2.1 Increasing preference for home care services to drive market 99
9.2.1.3 Mobile lifts 100
9.2.1.3.1 Lower risk of falls and reduced length of stay to propel demand 100
9.2.1.4 Sit-to-stand lifts 101
9.2.1.4.1 Ability to promote patient independence and reduce risk of musculoskeletal injuries among caregivers to drive growth 101
9.2.1.5 Bath & pool lifts 103
9.2.1.5.1 Availability of various options, including fixed, reclining, and lying bath lifts, to boost demand 103
9.2.2 SLINGS 104
9.2.2.1 Government policies and legislation promoting use of medical lifting slings to aid adoption 104
9.2.3 AIR-ASSISTED LATERAL TRANSFER MATTRESSES 105
9.2.3.1 Reusable air-assisted mattresses 105
9.2.3.1.1 Durability and long lifespan to enhance demand 105
9.2.3.2 Single-patient-use air-assisted mattresses 106
9.2.3.2.1 Disposable air-assisted mattresses to save costs and logistics associated with laundering 106
9.2.4 SLIDING SHEETS (ROLLERS/TUBES) 108
9.2.4.1 Effectiveness in enhancing patient safety and reducing workplace injuries to boost demand for sliding sheets 108
9.2.5 ACCESSORIES 109
9.2.5.1 Recurring need for replacement parts caused by regular wear and tear of patient handling equipment to support growth 109
9.3 MEDICAL BEDS 110
9.3.1 ELECTRIC BEDS 110
9.3.1.1 Increasing demand for adjustable beds that enhance both patient comfort and caregiver efficiency to boost market growth 110
9.3.2 MANUAL BEDS 111
9.3.2.1 Lower upfront costs and long-term durability of manual beds to continue to sustain market growth 111
9.3.3 SEMI-ELECTRIC BEDS 113
9.3.3.1 Lightweight design, ease of transport, and sufficient weight capacity to drive demand in home care settings 113
9.3.4 SMART BEDS 114
9.3.4.1 Rising demand for advanced patient monitoring and safety solutions to propel market 114
9.4 MOBILITY EQUIPMENT 115
9.4.1 WHEELCHAIRS & SCOOTERS 116
9.4.1.1 Powered wheelchairs 116
9.4.1.1.1 Better patient mobility and more customization options to increase demand 116
9.4.1.2 Mobility scooters 118
9.4.1.2.1 Advancements in design and rising demand for lifestyle-enhancing mobility solutions to continue to drive adoption of mobility scooters 118
9.4.1.3 Manual wheelchairs 119
9.4.1.3.1 Simplicity and durability of manual wheelchairs, along with their independence from battery charging to make them preferred option for both patients and caregivers 119
9.4.1.4 Smart wheelchairs 120
9.4.1.4.1 Rising global disability rates and demand for autonomous mobility equipment to drive market 120
9.4.2 AMBULATORY AIDS 122
9.4.2.1 Walkers 122
9.4.2.1.1 Growing geriatric population worldwide and increased awareness of fall prevention to increase demand for walkers 122
9.4.2.2 Canes 123
9.4.2.2.1 Rising aging population with balance impairments and mobility limitations to drive market growth 123
9.4.2.3 Crutches 124
9.4.2.3.1 Increasing incidence of lower-limb injuries to drive growth of crutches segment 124
9.5 BATHROOM & TOILET ASSIST EQUIPMENT 125
9.5.1 COMMODE CHAIRS 126
9.5.1.1 Growing preference for home healthcare and aging in place to support adoption of commode chairs in home care and rehabilitation settings 126
9.5.2 SHOWER CHAIRS 127
9.5.2.1 Enhanced product designs, featuring anti-slip legs, adjustable heights, and padded seats to contribute to adoption of shower chairs 127
9.5.3 TRANSFER BENCHES 129
9.5.3.1 Increasing need for safe and independent bathroom transfers among elderly and mobility-impaired patients to fuel growth 129
9.6 STRETCHERS & TRANSPORT CHAIRS 130
9.6.1 INCREASING DEMAND FOR SAFE AND EFFICIENT PATIENT TRANSPORTATION TO DRIVE SEGMENTAL GROWTH 130
10 PATIENT HANDLING EQUIPMENT MARKET, BY APPLICATION 132
10.1 INTRODUCTION 133
10.2 ACUTE CARE 133
10.2.1 RISING NUMBER OF ACCIDENTS AND NEED FOR ADVANCED EMERGENCY AND TRAUMA CARE TO DRIVE MARKET GROWTH 133
10.3 LONG-TERM CARE 134
10.3.1 RISING AGING POPULATION AND INCREASING PREVALENCE OF CHRONIC CONDITIONS & DISABILITIES TO BOOST MARKET GROWTH 134
10.4 REHABILITATION CARE 135
10.4.1 INCREASING GLOBAL DEMAND FOR REHABILITATION SERVICES FUELED BY RISE IN CHRONIC CONDITIONS TO DRIVE MARKET 135
10.5 BARIATRIC CARE 137
10.5.1 GROWING OBESE POPULATION TO SUPPORT MARKET GROWTH 137
10.6 OTHER APPLICATIONS 138
11 PATIENT HANDLING EQUIPMENT MARKET, BY END USER 139
11.1 INTRODUCTION 140
11.2 HOSPITALS 140
11.2.1 RISING PATIENT ADMISSIONS IN HOSPITALS REQUIRING SAFE AND EFFICIENT MOBILITY EQUIPMENT TO PROPEL MARKET GROWTH 140
11.3 HOME HEALTHCARE 141
11.3.1 RISING GERIATRIC POPULATION REQUIRING SAFE, IN-HOME MOBILITY SUPPORT TO DRIVE SEGMENTAL GROWTH 141
11.4 ELDER CARE FACILITIES 143
11.4.1 GROWING ADOPTION OF ERGONOMIC, EFFICIENT PATIENT HANDLING EQUIPMENT BY ELDER CARE FACILITIES TO SUPPORT MARKET GROWTH 143
11.5 REHABILITATION FACILITIES 144
11.5.1 RISING GLOBAL BURDEN OF DISABILITIES REQUIRING LONG-TERM MOBILITY SUPPORT TO DRIVE SEGMENTAL GROWTH 144
11.6 OTHER END USERS 145
12 PATIENT HANDLING EQUIPMENT MARKET, BY REGION 147
12.1 INTRODUCTION 148
12.2 NORTH AMERICA 149
12.2.1 US 154
12.2.1.1 US to dominate North American patient handling equipment market during forecast period 154
12.2.2 CANADA 158
12.2.2.1 Growth in disabled population to fuel Canadian patient handling equipment market 158
12.3 EUROPE 162
12.3.1 GERMANY 168
12.3.1.1 Germany to dominate European patient handling equipment market during forecast period 168
12.3.2 UK 172
12.3.2.1 Rising government investment in hospital infrastructure to drive demand for patient handling equipment in UK 172
12.3.3 FRANCE 176
12.3.3.1 High healthcare expenditure and government investment to foster rapid market growth for patient handling equipment in France 176
12.3.4 ITALY 180
12.3.4.1 Italy’s rapidly aging population and rising injury rates to drive growth in patient handling equipment market 180
12.3.5 SPAIN 184
12.3.5.1 Growing disability prevalence and mobility challenges to fuel market 184
12.3.6 REST OF EUROPE 188
12.4 ASIA PACIFIC 193
12.4.1 CHINA 198
12.4.1.1 China to dominate Asia Pacific patient handling equipment market during forecast period 198
12.4.2 INDIA 203
12.4.2.1 Chronic disease burden and expanding healthcare infrastructure to support growth of patient handling equipment in India 203
12.4.3 JAPAN 207
12.4.3.1 High prevalence of caregiver-related musculoskeletal disorders to fuel market expansion in Japan 207
12.4.4 AUSTRALIA 211
12.4.4.1 Aging population and growing preference for home-based care to drive market growth 211
12.4.5 SOUTH KOREA 216
12.4.5.1 Increasing diabetes and CKD prevalence to drive market growth 216
12.4.6 REST OF ASIA PACIFIC 220
12.5 LATIN AMERICA 224
12.5.1 BRAZIL 229
12.5.1.1 Chronic disease burden and major hospital expansions to significantly drive market growth 229
12.5.2 MEXICO 233
12.5.2.1 Rising obesity rates and associated hospitalization needs to propel market growth 233
12.5.3 REST OF LATIN AMERICA 237
12.6 MIDDLE EAST & AFRICA 241
12.6.1 GCC COUNTRIES 246
12.6.1.1 Rising healthcare infrastructure investments to drive market 246
12.6.2 REST OF MIDDLE EAST & AFRICA 250
13 COMPETITIVE LANDSCAPE 255
13.1 OVERVIEW 255
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 255
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PATIENT HANDLING EQUIPMENT MARKET 255
13.3 REVENUE ANALYSIS, 2021–2025 257
13.4 MARKET SHARE ANALYSIS, 2025 257
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 260
13.5.1 STARS 260
13.5.2 EMERGING LEADERS 260
13.5.3 PERVASIVE PLAYERS 260
13.5.4 PARTICIPANTS 260
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 262
13.5.5.1 Company footprint 262
13.5.5.2 Region footprint 263
13.5.5.3 Type footprint 264
13.5.5.4 Application footprint 265
13.5.5.5 End-user footprint 266
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 267
13.6.1 PROGRESSIVE COMPANIES 267
13.6.2 RESPONSIVE COMPANIES 267
13.6.3 DYNAMIC COMPANIES 267
13.6.4 STARTING BLOCKS 267
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 269
13.6.5.1 Detailed list of key startup/SME players 269
13.6.5.2 Competitive benchmarking of key emerging players/startups 269
13.7 COMPANY VALUATION & FINANCIAL METRICS 270
13.7.1 FINANCIAL METRICS 270
13.7.2 COMPANY VALUATION 270
13.8 BRAND/PRODUCT COMPARISON 271
13.9 COMPETITIVE SCENARIO 272
13.9.1 PRODUCT LAUNCHES 272
13.9.2 DEALS 275
13.9.3 EXPANSIONS 277
13.9.4 OTHER DEVELOPMENTS 278
14 COMPANY PROFILES 279
14.1 KEY PLAYERS 279
14.1.1 ARJO 279
14.1.1.1 Business overview 279
14.1.1.2 Products offered 281
14.1.1.3 Recent developments 284
14.1.1.3.1 Product launches 284
14.1.1.3.2 Deals 285
14.1.1.3.3 Expansions 285
14.1.1.3.4 Other developments 285
14.1.1.4 MnM view 286
14.1.1.4.1 Right to win 286
14.1.1.4.2 Strategic choices 286
14.1.1.4.3 Weaknesses & competitive threats 286
14.1.2 BAXTER INTERNATIONAL, INC. 287
14.1.2.1 Business overview 287
14.1.2.2 Products offered 288
14.1.2.3 Recent developments 291
14.1.2.3.1 Product launches 291
14.1.2.4 MnM view 291
14.1.2.4.1 Right to win 291
14.1.2.4.2 Strategic choices 291
14.1.2.4.3 Weaknesses & competitive threats 291
14.1.3 SAVARIA 292
14.1.3.1 Business overview 292
14.1.3.2 Products offered 293
14.1.3.3 Recent developments 296
14.1.3.3.1 Expansions 296
14.1.3.4 MnM view 297
14.1.3.4.1 Right to win 297
14.1.3.4.2 Strategic choices 297
14.1.3.4.3 Weaknesses & competitive threats 297
14.1.4 STRYKER CORPORATION 298
14.1.4.1 Business overview 298
14.1.4.2 Products offered 299
14.1.4.2.1 Expansions 301
14.1.4.3 MnM view 301
14.1.4.3.1 Right to win 301
14.1.4.3.2 Strategic choices 301
14.1.4.3.3 Weaknesses & competitive threats 302
14.1.5 DRIVE DEVILBISS HEALTHCARE 303
14.1.5.1 Business overview 303
14.1.5.2 Products offered 303
14.1.5.3 Recent developments 306
14.1.5.3.1 Product launches 306
14.1.5.3.2 Deals 306
14.1.5.4 MnM view 307
14.1.5.4.1 Right to win 307
14.1.5.4.2 Strategic choices 307
14.1.5.4.3 Weaknesses & competitive threats 307
14.1.6 INVACARE AMERICA 308
14.1.6.1 Business overview 308
14.1.6.2 Products offered 308
14.1.7 ETAC AB 310
14.1.7.1 Business overview 310
14.1.7.2 Products offered 310
14.1.7.3 Recent developments 312
14.1.7.3.1 Product launches 312
14.1.7.3.2 Deals 313
14.1.8 GF HEALTH PRODUCTS, INC. 314
14.1.8.1 Business overview 314
14.1.8.2 Products offered 315
14.1.8.3 Recent developments 318
14.1.8.3.1 Product launches 318
14.1.8.3.2 Deals 319
14.1.9 GULDMANN INC. 320
14.1.9.1 Business overview 320
14.1.9.2 Products offered 321
14.1.10 JOERNS HEALTHCARE 324
14.1.10.1 Business overview 324
14.1.10.2 Products offered 324
14.1.10.3 Recent developments 325
14.1.10.3.1 Product launches 325
14.1.10.3.2 Deals 325
14.1.11 MEDLINE 326
14.1.11.1 Business overview 326
14.1.11.2 Products offered 327
14.1.11.3 Recent developments 328
14.1.11.3.1 Deals 328
14.1.12 PRISM HEALTHCARE GROUP 329
14.1.12.1 Business overview 329
14.1.12.2 Products offered 329
14.1.12.3 Recent developments 330
14.1.12.3.1 Deals 330
14.1.12.3.2 Expansions 331
14.1.13 LINET GROUP SE 332
14.1.13.1 Business overview 332
14.1.13.2 Products offered 332
14.1.13.3 Recent developments 333
14.1.13.3.1 Deals 333
14.1.13.3.2 Expansions 333
14.1.14 STIEGELMEYER GMBH & CO. KG (A STIEGELMEYER-GROUP COMPANY) 334
14.1.14.1 Business overview 334
14.1.14.2 Products offered 334
14.1.15 DHCARE 336
14.1.15.1 Business overview 336
14.1.15.2 Products offered 336
14.1.15.3 Recent developments 337
14.1.15.3.1 Product launches 337
14.1.15.3.2 Deals 338
14.1.15.3.3 Expansions 338
14.1.16 MALVESTIO SPA 339
14.1.16.1 Business overview 339
14.1.16.2 Products offered 339
14.1.17 EZ WAY INC. 340
14.1.17.1 Business overview 340
14.1.17.2 Products offered 340
14.1.18 PERMOBIL HOLDING AB 344
14.1.18.1 Business overview 344
14.1.18.2 Products offered 345
14.1.18.3 Recent developments 345
14.1.18.3.1 Product launches 345
14.1.18.3.2 Deals 346
14.1.18.3.3 Other developments 346
14.1.19 MERITS HEALTH PRODUCTS, INC. 347
14.1.19.1 Business overview 347
14.1.19.2 Products offered 347
14.1.19.3 Recent developments 349
14.1.19.3.1 Deals 349
14.1.20 WINNCARE GROUP 350
14.1.20.1 Business overview 350
14.1.20.2 Products offered 350
14.1.20.3 Recent developments 351
14.1.20.3.1 Deals 351
14.2 OTHER PLAYERS 352
14.2.1 PARAMOUNT BED HOLDINGS CO., LTD. 352
14.2.2 SUNRISE MEDICAL 353
14.2.3 PRIDE MOBILITY PRODUCTS CORP. 355
14.2.4 ANTANO GROUP 356
14.2.5 OSSENBERG GMBH 357
15 RESEARCH METHODOLOGY 358
15.1 RESEARCH DATA 358
15.1.1 SECONDARY DATA 359
15.1.1.1 Key data from secondary sources 360
15.1.2 PRIMARY DATA 360
15.1.2.1 Key data from primary sources 362
15.1.2.2 Key industry insights 363
15.2 MARKET SIZE ESTIMATION 364
15.3 MARKET BREAKDOWN & DATA TRIANGULATION 368
15.4 MARKET RANKING ANALYSIS 369
15.5 STUDY ASSUMPTIONS 369
15.6 RESEARCH LIMITATIONS 369
15.6.1 METHODOLOGY-RELATED LIMITATIONS 369
15.6.2 SCOPE-RELATED LIMITATIONS 370
15.7 RISK ASSESSMENT 370
16 APPENDIX 371
16.1 DISCUSSION GUIDE 371
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 378
16.3 CUSTOMIZATION OPTIONS 380
16.4 RELATED REPORTS 380
16.5 AUTHOR DETAILS 381